BioNTech SE Dividend History (BNTX)

🤑 BioNTech SE has distributed a total of 1 dividends over the course of a year

About

About BioNTech SE

BioNTech SE is a German biotechnology company, founded in 2008 by CEO Uğur Şahin, along with Özlem Türeci and Christoph Huber. The company is headquartered in Mainz, Germany, and is renowned for its pioneering work in developing mRNA-based therapies, notably in the field of personalized cancer treatment and infectious diseases. BioNTech gained global prominence for its collaboration with Pfizer to develop one of the first COVID-19 vaccines, BNT162b2, which received emergency use authorization in multiple countries in late 2020. As of the latest available financial data, BioNTech has reported substantial revenue growth, driven primarily by the widespread distribution of the COVID-19 vaccine. The company's mission focuses on harnessing the immune system to fight diseases and remains at the forefront of medical innovation.

Website: https://www.biontech.de

Other companies you might be interested in

Apple Inc.

Microsoft Corporation

Exxon Mobil Corporation

Verizon Communications Inc.

AT&T Inc.

Chevron Corporation

Company News

5 Top Stocks to Buy in December

The article discusses five stocks that are recommended to buy in December 2024: Intel, Occidental Petroleum, BioNTech, McCormick, and Coca-Cola. The article provides analysis and reasons for the positive sentiment on these stocks.

The Motley Fool · Published on Wed Dec 04 2024

Other companies featured in this article: INTC OXY MKC KO

Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth

Federal Reserve Chair Powell stated that the economy is strong and does not require immediate rate cuts, contrary to market expectations. This caused selling pressure in various sectors, including healthcare, defense, and big tech stocks.

Benzinga · Published on Fri Nov 15 2024

Other companies featured in this article: BA AAPL AMZN GOOG GOOGL

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition

BioNTech has acquired Biotheus, a Chinese biotech company, for over $800 million upfront plus potential milestone payments. The deal gives BioNTech full rights to Biotheus' late-stage bispecific antibody BNT327/PM8002, which has shown promising results in various cancer types.

Benzinga · Published on Wed Nov 13 2024

Previous Payouts (1)

The most recent dividend BioNTech SE paid out was on June 17, 2022 (901 days ago) for $2.1322 per share

Pay Date	Amount
June 17, 2022	$2.1322

Dividend data last updated Wed, 04 Dec 2024 23:33:04 GMT UTC